Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifeward, formerly known as ReWalk Robotics and Argo Medical Technologies, is a medical device company that develops and commercializes wearable robotic exoskeletons and rehabilitation technologies. The company's primary product, the ReWalk Personal Exoskeleton, is a battery-powered system that allows individuals with spinal cord injuries to stand and walk. Lifeward also offers the ReStore soft exo-suit, which is used in clinical settings to assist stroke survivors with gait training. Following the acquisition of AlterG in 2023, the company expanded its portfolio to include anti-gravity treadmill systems for physical therapy and athletic training. Lifeward is headquartered in the United States and maintains significant research and development operations in Israel. The company is publicly traded on the NASDAQ and focuses on improving the quality of life for individuals with neurological and mobility impairments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Argo Medical Technologies.